References
- CelliBRDecramerMWedzichaJAATS/ERS Task Force for COPD Research. ATS/ERS research questions in COPDEur Respir J20154587990525829431
- Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet]Global Strategy for the Diagnosis, Management and Prevention of COPD2017 Available from: http://www.goldcopd.orgAccessed April 13, 2018
- GBD 2015 Chronic Respiratory Disease CollaboratorsGlobal, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysisLancet Respir Med20155691706
- CazzolaMPageCCalzettaLPharmacology and therapeutics of bronchodilatorsPharmacol Rev20126445050422611179
- SlebosDKloosterKKoegelenbargCTargeted lung denervation for moderate to severe COPD: a pilot studyThorax20157041141925739911
- MeguroMBarleyESpencerSJonesPDevelopment and validation of an improved, COPD-specific version of the St George Respiratory QuestionnaireChest200713245646317646240
- van der MolenTWillemseBSchokkerSten HackenNPostmaDJuniperEDevelopment, validity and responsiveness of the Clinical COPD QuestionnaireHealth Qual Life Outcomes200311312773199
- BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax19995458158610377201
- MaltaisFHamiltonAMarciniukDImprovements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPDChest20051281168117816162703
- MillerMHankinsonJBrusascoVATS/ERS Task Force: standardization of lung function testing: standardization of spirometryEur Respir J20052631933816055882
- WangerJClausenJCoatesAATS/ERS Task Force: standardisation of lung function testing; standardisation of the measurement of lung volumesEur Respir J20052651152216135736
- WeismanIMarciniukDMartinexFATS/ACCP statement on cardiopulmonary exercise testingAm J Respir Crit Car Med2003167211277
- ATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoriesATS statement: guidelines for the six-minute walk testAm J Respir Crit Car Med2002166111117
- KistemakerLOenemaTMeursHGossensRRegulation of airway inflammation and remodel by muscarinic receptors: perspectives of anticholinergic therapy in asthma and COPDLife Sci2012911126113322406302
- PowrieDWilkinsonTDonaldsonGEffect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPDEur Respir J200730427478
- BradleyGHaleTPimbleHRolandsonRNobleMEffect of vagotomy on the breathing pattern and exercise ability in emphysematous patientsClin Sci1982623113196800681
- GayMRienhoffWFurther observations on the treatment of intractable bronchial asthma by bilateral resection of the pulmonary plexusJ Allergy194213626631
- Dimitrov-SzokodiDHusvetiABaloghGLung denervation in the therapy of intractable bronchial asthmaJ Thoracic Surg195733166184
- BelmonteKCholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary diseaseProc Am Thorac Soc2005229730416267352
- ChangHYLoLWChouYHEffect of vagotomy on the activity of cardiac autonomic ganglia: insight from left atrial high density frequency mappingInt J Cardiol201622043543927390967
- HananiaNBartolomeCDonohueJMartinUBronchodilator reversibility in COPDChest20111401055106321972384
- KistemakerLSlebosDMeursHKerstjensHGossensRAnti-inflammatory effect of targeted lung denervation in patients with COPDEur Respir J2015461489149226341988
- VaccaGRanderathWGillissenAInhibition of granulocyte migration by tiotropium bromideRespir Res2011122421352583
- BuhlingFLiederNKuhlmannUWaldburgNWelteTTiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitroRespir Med20071012386239417761412
- JonesPDonohueJNedelmanJPascoeSPinaultGLassenCCorrelating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysisRespir Res20111216122206353